GU Cast | Urology Podcast

Updated: 15 Nov 2025 • 213 episodes
www.gucast.org

A urology podcast, focussing on prostate cancer, kidney cancer, bladder cancer, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org 

Show episodes

We recently hosted another live webinar for our Gold Partners, Mundipharma,  this time asking the question, "Is high-risk BCR actually metastatic prostate cancer??". It"s a reasonable question! This podcast was anchored from the GU Cast studio in Melbourne by usual hosts, Renu Eapen and Declan Murphy, joined in person

90 min
00:00
01:30:59
No file found

Dr Amar Kishan (Radiation Oncologist, UCLA, USA), made lots of headlines recently when he presented data from the phase II randomised LUNAR trial of SABR +/- LuPSMA in patients with oligometastatic prostate cancer. So we were very happy when he turned up in Melbourne recently and popped into the GU Cast studio for a ch

34 min
00:00
34:24
No file found

Fun today as we go to the OR to test drive some high-fidelity radical prostatectomy models and chat with the team behind UroTrainer - world leaders in urologic simulation. Urologists Gonzalo Vitagliano and Maxi Ringa join us from Buenos Aries to tell us all about UroTrainer and why they have worked hard to create these

24 min
00:00
24:58
No file found

One of our favourite meetings of the year! The EAU Robotic Urology Section (ERUS) Annual Meeting took place in London recently and was an unashamed exposition of robotic surgery in urology. More than 30 amazing live surgeries, and some fantastic plenary sessions focussing on technical aspects. Multiple different robots

50 min
00:00
50:17
No file found

Episode 3 of our monthly GU Cast Journal Club and today we focus on one classic paper in Urology, and one from recent times - the ERSPC randomised trial of screening in prostate cancer, and the NIAGARA trial evaluating peri-operative immunotherapy in muscle-invasive bladder cancer.  We are delighted to welcome back our

32 min
00:00
32:13
No file found

Another of our deep-in-the-weeds theranostic webinars in conjunction with our friends at ProsTiC, and the Prostate Cancer Foundation. This one focussed on Terbium-161, a very exciting new option in metastatic prostate cancer.  Your hosts are Dr Renu Eapen and Professor Michael Hofman, with Dr Howard Soule and Dr Andrea

83 min
00:00
01:23:23
No file found